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Abstract
Gallbladder carcinoma remains the most common cancer originating from the
biliary tract, which is associated with poor prognosis and poor survival rates. It is
estimated that only one-third of patients with histopathological diagnostic of gall-
bladder cancer had been correctly diagnosed preoperatively, in the remaining cases
the diagnostic being established intraoperatively or postoperatively, based on the
histopathological examination. Moreover, although surgery remains the most
appropriate therapeutic approach in order to improve survival, it is estimated that
only 25% of cases with gallbladder carcinomas present resectable lesions. The cur-
rent chapter reviews the most appropriate surgical options in patients diagnosed
with both early stage and advanced stage gallbladder cancer, by minimally invasive
as well as by open approach. In the meantime, the therapeutic strategies in inciden-
tally diagnosed gallbladder cancer will be discussed.
Keywords: gallbladder cancer, atypical hepatic resection, bile duct resection,
lymph node dissection, survival
1. Introduction
Gallbladder carcinoma represents the most frequently encountered malignant
tumor originating from the biliary tract, with a low rate of diagnostic, a low rate of
surgical treatment, and an extremely poor long-term prognostic [1, 2].
The global incidence of gallbladder cancer is low (<2/100,000 cases), but sig-
nificant differences given by the regional and racial criteria have been reported [3].
Therefore, it has been demonstrated that women are more commonly affected
by this malignancy; in regard to the patients’ age, it seems that the incidence of
gallbladder cancer significantly increases after the age of 40. In terms of race, it
seems that the highest risk for gallbladder carcinoma has been reported among
people from Chile, Poland, India, Japan, and Israel [4].
As for the risk factors incriminated for gallbladder cancer development, it seems
that the presence and the dimensions of gallstones increased the body mass index as
well as multiparity significantly influence it [5, 6].
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2. Treatment options in gallbladder carcinoma
Surgery remains the most efficient therapeutic strategy in order to achieve long-
term survival in gallbladder carcinoma patients. However, only a limited number of
cases diagnosed with this pathology are amenable to surgery due to the extent of the
disease. A generic observation pointed out that only one-third of gallbladder cancer
patients are diagnosed preoperatively, and, among these cases, only one quart
present resectable lesions [7, 8].
Incidental gallbladder carcinoma also represents a rare condition, ranging from
less than 3% of all cases; however, it seems that that this situation is more common
in female patients, over 65 years of age who are known with gallbladder stones or
cholecystitis and originating from Asian or African descendants [9–11]. In order to
provide a rapid diagnostic in such cases, intraoperative frozen section examinations
have been proposed with good results [12]. As for the diagnostic criteria of inci-
dental gallbladder carcinoma, certain authors proposed that in this category cases in
which the diagnostic is not suspected during surgery or on gross examination of the
specimen should be included, the neoplastic process being only detected at the
histopathological examination [13].
When it comes to the extent of the resection, this parameter is dictated by the
stage of the tumor; however, improvement of the surgical techniques in regard to
liver resection and even liver transplantation as well as in regard to the periopera-
tive management of these patients conducted to an increasing number of cases who
can benefit from radical surgery for gallbladder carcinoma [14, 15]. Cases
presenting advanced stage disease which is no longer amenable to surgery with
curative intent can also benefit from palliative procedures in order to minimize the
effects of gastrointestinal or biliary obstruction [2]. In selected cases adjuvant
therapies such as chemotherapy or radiotherapy might be also associated in order to
improve the overall outcomes [2].
3. Surgery as a therapeutic option in gallbladder carcinoma patients
The aggressivity of gallbladder cancer was maybe best defined by Alfred
Blalock, an American surgeon who stated in 1924 that “in malignancy of the gall-
bladder, when a diagnosis can be made without exploration, no operation should be
performed, inasmuch as it only shortens the patient’s life” [7]. This statement was
unfortunately confirmed by a latter publication which demonstrated that on a
group of 6222 patients, the cumulative survival rate was of 5–8 months, while the
5-year survival rate did not surpass 4% [16].
However, in the next decades, due to the improvement of the surgical tech-
niques, more extended resections have been safely performed in order to cure this
malignancy. This fact was maybe best demonstrated by a Canadian study which
analyzed the outcomes of patients submitted to surgery for gallbladder cancer
during a 12-year period; cases submitted to surgery in the second part of this
interval reported an overall 5-year survival rate of 35%, significantly higher than the
first period (in which the 5-year overall survival rate did not surpass 7%) [17].
Whenever gallbladder cancer is suspected, the therapeutic desiderate consists of
complete tumoral resection with negative resection margins. In early stages of the
disease, this desiderate is achieved if cholecystectomy en bloc with the surrounding
liver bed and the regional lymph nodes are excised. In cases in which surgery is
planned for a presumed benign disease and at the time of exploration the suspicion
of malignancy is raised, hepatic resection should be associated; however, if the
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surgical team is not prepared to perform liver resection, the patient should be
transferred in a specialized center in order to be submitted to a complete surgical
procedure. This sequencing of the surgical procedure seems not to influence the
long-term survival of the patient [7, 18].
In cases diagnosed in early stages of the disease, it seems that a simple cholecys-
tectomy is enough in order to achieve a good control of the disease; therefore, in
stage T1a tumors, the rate of cure after simple cholecystectomy ranges between 85
and 100% [19, 20], while in stage T1b tumors, a more extended local resection
should be performed in order to control the disease [21]. This extended resection
usually refers to the necessity of associating a wedge hepatic resection [22].
Whenever a T2 gallbladder carcinoma is suspected, a more aggressive surgical
procedure including adjacent liver resection involving the segments IVb and V and
regional lymph node dissection should be added to improve the outcomes; there-
fore, it is estimated that, while in cases diagnosed with stage T2 gallbladder cancer,
the 5-year overall survival reaches 80% if an extended surgical procedure is
performed, significantly higher than simple cholecystectomy (in these cases, the
5-year overall survival ranges between 20 and 40%) [23, 24]. The necessity of
resecting segments IVb/Vb is explained by the venous drainage of the gallbladder,
which seems to be directed in this area [25].
An interesting study regarding the most appropriate surgical strategy in cases
suspected for early gallbladder carcinoma diagnosed during or after cholecystec-
tomy was conducted by Nitta et al. and was published in the Annals of Medicine and
Surgery in 2018 [12]; the study included 529 patients submitted to cholecystectomy
in Medico Shunju Shiroyama Hospital, Osaka, Japan, between April 2009 and
December 2017. Among these cases, there were eight cases diagnosed with gall-
bladder cancer; five out of the eight cases were submitted to surgery for stones,
while the remaining three cases were submitted to surgery for cholecystitis.
Whenever gallbladder cancer was proven at the frozen section, conversion to
open surgery occurred, and the patient was submitted to gallbladder bed resection,
liver resection of the segments IVb–Vb alone or in association with lymph node
dissection; in the meantime if invasion of the cystic duct stump was found, pro-
phylactic common bile duct excision was associated. After a median follow-up
period of 17.9 months, five out of the eight patients were still alive; one patient
initially diagnosed with stage IIIA gallbladder cancer died due to peritoneal carci-
nomatosis, while the other two cases died from other diseases [12].
Another interesting topic when it comes to incidental gallbladder carcinoma
regards the timing of reoperation; therefore, if the patient is submitted to surgery
for presumed benign pathology of the gallbladder and the histopathological studies
demonstrate the presence of a malignant transformation at this level, it seems that
the best outcomes are reported if early reoperation is performed. Therefore, in the
study conducted by Muratore et al. on 11 patients with incidental gallbladder can-
cer, the authors demonstrated that the best long-term outcomes were seen if radical
resection was performed within the first 2.2 months after cholecystectomy [26].
Moreover, the extent of the liver resection should be established in concordance
with the local aspect: if the right portal pedicle seems to be involved, liver resection
should consist of a right hepatectomy.
In cases suitable for both wedge resection and typical hepatectomy, the extent of
liver resection should be carefully tailored due to the fact that in certain cases wedge
resection might be insufficient (and associated with positive resection margins),
while typical resection might be associated with increased morbidity rates; more-
over, the decision of performing a right hepatectomy in patients associating cirrho-
sis should be taken after analyzing the risk of an insufficient liver remnant [25].
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Study, year No
of
cases
Stage
at
surgery
Type of surgery Recurrence
rate
Sites of
recurrence
Lymph node
metastasis rate
Survival rate Gallbladder carcinoma
related death
Factors
influencing
survival
Lee (review
study) [32]
1266 T1a—
706
cases
T1b—
560
cases
Laparoscopic
cholecystectomy
1.1% Common
bile duct
2.5% (10.9% of
T1b lesions and
1.8% of T1a
lesions)
100% at 5-year follow-up Eight cases with T1a lesions
and 52 cases with T1b
lesions died due to
recurrent disease
Nitta (single-
center study)
[12]
8 Tis—2
cases
T1b—
1 pt.
T2—3
cases
Laparoscopic
cholecystectomy—5
cases
Open cholecystectomy
—3 cases
Wedge resection of the
gallbladder bed—2 cases
Segmental resection—1
case
12.5% Peritoneal NR After a median follow-up period of
17.9 months, one case died due to
the progression of the disease,
while other two cases died due to
other causes
One case— peritoneal
carcinomatosis
Aldossary
(single-
center study)
[33]
76 Stage I
—3
cases
Stage
IIA—13
cases
Stage
IIB—
1 pt.
Stage
IIIB—2
cases
Stage
IVB—
57 cases
21 cases—resection
55 cases—unresectable
lesions
10.5% NR NR 20.5% for the entire cohort 71% of cases presented
with unresectable lesions
and died of disease
Resectability
of the lesions
Stage at
diagnostic
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Study, year No
of
cases
Stage
at
surgery
Type of surgery Recurrence
rate
Sites of
recurrence
Lymph node
metastasis rate
Survival rate Gallbladder carcinoma
related death
Factors
influencing
survival
Shen
(multicentric
study) [2]
2379 Stage I
—3.6%
Stage II
—7.3%
Stage
III A—
341
cases
Stage
IIIB—
333
cases
Stage
IVA—
253
cases
Stage
IVB—
838
cases
NR—
108
cases
Radical resection—641
cases
Extended radical
resection—82 cases
Palliative surgery—499
cases
Drainage—261 cases
NR NR 29.7% NR NR NR
Yildirim
(single-
center study)
[34]
65 T1a—5
cases
T1b—8
cases
T2—34
cases
T3—18
cases
Extended
cholecystectomy—28
cases
Simple cholecystectomy
—37 cases
83.00% NR NR Median survival—41 months
5-year overall survival rate—32%
45 cases Lymph node
status
Tumor stage
Type of
surgery
Vascular/
neural
invasion
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Study, year No
of
cases
Stage
at
surgery
Type of surgery Recurrence
rate
Sites of
recurrence
Lymph node
metastasis rate
Survival rate Gallbladder carcinoma
related death
Factors
influencing
survival
Jin
(multicentric
study) [35]
613 NR Cholecystectomy—150
cases
Partial hepatectomy—
249 cases
Extensive hepatectomy
—25 cases
Palliative/other
procedures—108 cases
Diagnostic—81 cases
NR NR NR NR NR NR
Creasy,
single-center
study [36]
74 IIIA—2
cases
IIIB—
10 cases
IVA—6
cases
IVB—
43 cases
Surgery with curative
intent including
resection of segments 4
and 5—6 cases
Hemihepatectomy—2
cases
Extended hepatectomy
—2 cases
Bile duct resection—10
cases
NR NR NR Median overall survival—
14.2 months
61 cases died due to the
progression of the disease
Completeness
of
cytoreduction
Table 1.
The largest studies conducted on the theme of the role of surgical approach in gallbladder cancer patients.
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Whenever extended liver resections are expected with a future liver remnant
lesser than 25%, a portal vein embolization might be taken into consideration [27].
Another interesting subject is the one regarding the necessity of routinely associa-
tion of caudate lobe resection; while the Japanese surgeons stand for routine caudate
lobe resection, in the Western countries this practice is not part of the standard
protocol [25, 28].
When it comes to the lymphatic spread of gallbladder cancer, anatomy studies
demonstrated that the first involved lymph nodes are located along the biliary tree
and represented by the cystic, common hepatic, and common bile duct lymph nodes;
going further, the next involved stations are located along the pancreaticoduodenal,
common hepatic artery, and coeliac axis nodes. The most distant lymph node stations
are located at the level of the pancreatic body and tail; whenever tumoral cells are
encountered at this level, the case is considered to have distant metastases [29].
As for the extent of the lymph node dissection, different opinions have been
proposed so far: since certain authors recommended a local lymph node dissection
involving the stations from the hepatoduodenal ligament, other surgeons routinely
associate retropancreatic and celiac trunk lymph node dissection [7].
In cases presenting more advanced stages of the disease such as T3 gallbladder
carcinomas, more extended upper abdominal resections might be taken into con-
sideration; if the tumoral process involves the biliary duct, bile duct resection and
anastomosis should be performed. Moreover if the adjacent organs (such as gastro-
intestinal tract or colon) are involved, segmental resections might be needed in
order to achieve complete resection of the malignant process.
Special care should be provided for cases associating gallbladder cancer and
stones; such patients might present local adhesions which might induce a difficult
differentiation between the inflammatory and malignant transformations; there-
fore, a large resection is advisable in order to avoid incomplete resection. Whenever
the desiderate of negative resection margins is achieved, long-term survival should
be expected; in such cases the rate of 5-year overall survival ranges between 30 and
50% [30, 31].
Contrarily, patients diagnosed with stage T4 gallbladder lesions report a poor
outcome, surgery with curative intent being suitable in rare cases. In such patients
surgery is most commonly performed with palliative intent, while the overall sur-
vival remains extremely poor.
Figure 1.
Intraoperative aspect after right hepatectomy extended to the caudate lobe for locally advanced gallbladder
carcinoma. Association of common bile duct resection was performed.
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Figure 2.
Incidental finding—gallbladder carcinoma.
Figure 3.
Dissection of the cystic duct.
Figure 4.
The final aspect after cholecystectomy en bloc with lymph node excision.
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The largest studies, which were focused on the role of surgery in gallbladder
cancer patients, are summarized in Table 1.
Intraoperative aspects of patients submitted to surgery for gallbladder carci-
noma are shown in Figures 1–4.
4. Laparoscopic versus open approach in gallbladder cancer patients
Although laparoscopic cholecystectomy represents one of the most facile to be
performed minimally invasive procedures, there is still controversy regarding the
feasibility and safety of the laparoscopic approach in gallbladder cancer patients.
This fact is explained through the aspect that in such cases multiple upper abdom-
inal resections might be needed in order to control the disease; moreover, another
fact that should be taken into consideration when deciding for a minimally invasive
approach in gallbladder patients is related to the risk of port-site metastases devel-
opment.
One of the most recent studies which envisaged the efficacy and safety of the
laparoscopic approach in gallbladder cancer patients has been recently published by
the Chinese surgeons from Jiangsu [37]. The authors included in their study 102
patients with gallbladder carcinoma who were submitted to surgery between
August 2008 and August 2017 in a minimally invasive manner, 41 cases, or via an
open approach, 61 cases.
The authors demonstrated that there was no significant difference between the
operative blood loss, operative time, postoperative complications, R0 resection, and
tumor-related death between the two groups [37]. Moreover, the authors demon-
strated an improved postoperative outcome for patients submitted to a minimally
invasive procedure, while the long-term outcomes demonstrated similar overall
survival rates at 1 year, 3 years, and 5 years postoperatively. Moreover, the authors
analyzed the 5-year survival rate according to the stage at the initial diagnostic and
demonstrated that there was no significant difference in terms of survival for
patients submitted to surgery for Tis, T1b, T2, and T3 tumors in a minimally
invasive or open approach.
In terms of recurrences and metastases, the authors reported that there was no
difference in regard to the incisional site metastases between the two groups (4.9%
in the laparoscopic group and 3.3% in the open approach group). However, the
authors demonstrated that the risk of incisional metastases was increased in cases
presenting gallbladder rupture.
When it came to the recurrence time, it seems that patients submitted to an
open approach experienced relapsed disease earlier than those submitted to a
minimally invasive approach; however, this aspect was rather related to the fact
that among patients submitted to an open approach, a higher proportion of T3
tumors existed [37].
The subject of port-site metastases has been widely studied so far, in certain
cases excision of the port sites being proposed in order to minimize this risk
[38, 39].
One of the largest studies which debated the role of port-site resection in
laparoscopically treated gallbladder cancer patients was conducted by Fuks et al.
and was published in the Journal of Visceral Surgery [40]. The study included 218
patients with incidental gallbladder cancer who had been treated in a minimally
invasive manner between 1998 and 2008 in 21 centers in France; among these cases,
re-resection with curative intent was performed in 148 cases, 54 cases being also
submitted to port-site excision.
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Their results were compared to the ones reported in the remaining 94 patients
who did not undergo to port-site excision. There was no significant difference
between the two groups in terms of tumor stage or extent of resection. Port-site
metastases were encountered in a single patient who had been previously submitted
to port-site excision; it was the case of a patient who had been initially submitted to
surgery for a T3 gallbladder carcinoma and who died 15 months after resection due
to the development of peritoneal carcinomatosis.
However, the authors demonstrated that the 1-year, 3-year, and 5-year overall
survival rates were similar between the two categories of patients; moreover,
patients submitted to port-site excision developed an incisional hernia rate at the
site of port excision of 8% [40].
Therefore, the authors concluded that port-site excision should not be routinely
performed in such cases; an interesting aspect that was pointed out by the same
study was the one regarding the possible protective role, which could be given by
peritoneal frozen section surrounding the peritoneal trocar orifices in cases
presenting greater or equal to T2 tumors [40].
5. Postoperative complications after surgery for gallbladder carcinoma
Whenever surgery with curative intent is performed in gallbladder carcinoma
patients, the postoperative risk of developing complications seems to remain high at
both 30 and 90 days postoperatively. Therefore, although most studies take into
consideration the 30-day morbidity/mortality rate, it seems that maybe a more
adequate tool in order to quantify the postoperative outcomes is represented by the
90-day morbidity/mortality rate. This fact seems to be true not only in gallbladder
cancer patients but also in other malignancies such as pancreatic cancer and esoph-
ageal or gastric cancer [41, 42].
A recent study conducted on this theme by Goussous et al. and published in 2017
demonstrated that the postoperative mortality within the first 90 days postopera-
tively is 2.3-fold higher than the 30-day postoperative mortality [43]. Another
interesting aspect underlined by this study was the one that the 30-day and 90-day
mortality, respectively, was significantly correlated with the degree of tumoral
differentiation, with the presence of vascular and lymphatic invasion, with the stage
of the tumor, with incomplete resection, and with low-volume centers. Moreover,
the authors demonstrated the fact that even in cases submitted to surgery in a
minimally invasive manner, the 90-day mortality rate was significantly higher than
the 30-day mortality rate [43].
6. Factors predicting survival after surgery for gallbladder cancer
It seems that the most important prognostic factors predicting the long-term
outcomes after surgery for gallbladder carcinoma remain the stage of the disease at
the time of diagnostic (including tumoral and lymph node status) as well as the
completeness of resection [7, 18]. In the meantime, association of clinical signs as
jaundice is most often a sign of locally advanced/unresectable disease and therefore
is associated with poor rates of survival [44].
One of the most recent studies which were conducted on the theme of predictors
of curative resection and long-term survival in patients with gallbladder cancer was
published by Mishra et al. in the American Journal of Surgery [45]. The study
included 385 patients diagnosed with gallbladder cancer between September 2003
and December 2014 in the Academic Block, GB Pant Hospital, New Delhi, India.
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The authors demonstrated that cases presenting gastric outlet obstruction, weight
loss, abdominal lump, and obstructive jaundice were more likely to present
unresectable lesions.
Moreover, patients presenting at the time of initial diagnostic obstructive jaun-
dice presented significantly lower rates of 1-year, 3-year and 5-year overall survival
than those in whom jaundice had not been present at the time of diagnostic [45].
7. Palliative surgery for unresectable/metastatic gallbladder cancer
Due to the fact that a large proportion of patients with gallbladder cancer are
diagnosed in advanced stages of the disease, when surgery with curative intent is no
longer possible, palliative procedures might be needed in order to alleviate the
symptoms. In such cases, the most frequently reported symptoms necessitating
palliative procedures are represented by pruritus, cholangitis, jaundice, digestive
obstruction, or pain. However, in this subgroup of patients, the goal of surgery is a
pure palliative one, the overall survival ranging between 2 and 4 months [46, 47].
8. Conclusions
Gallbladder carcinoma remains an extremely aggressive malignancy which is
rarely diagnosed in early stages of the disease; therefore the overall survival rates
remain extremely poor, the most important predictors for long-term survival being
related to the stage at diagnostic as well as to the completeness of resection. How-
ever, it should not be omitted the fact that most often extended upper abdominal
resections might be needed in order to achieve an R0 resection; therefore such
patients should be addressed in high-volume centers.
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